Search
Search
Cell culture workflows present process challenges that can limit productivity and complicate scale-up. Foam accumulation in bioreactor systems disrupts oxygen transfer and culture monitoring. Metabolic requirements shift as cultures progress through exponential growth and stationary phases, creating conditions that reduce viability if left unaddressed. Fed-batch operations often encounter productivity plateaus that constrain titer achievement. Gibco functional additives are designed to address these defined challenges, supporting process development from early optimization through commercial manufacturing with consistent performance and documentation.
The Gibco functional additives portfolio encompasses specialized products designed to manage distinct culture challenges across bioreactor operations, metabolic support, and productivity enhancement. Each product addresses process requirements at a defined workflow stage in extended culture runs to enhance antibody production in fed-batch systems.
Selecting functional additives requires evaluating process requirements and workflow stages. Foam control depends on agitation and aeration strategies. Metabolic support reflects cell line characteristics and culture duration. Productivity goals in fed-batch systems may warrant titer enhancement. Functional reagents should align with development or cGMP standards. Functional additives perform effectively when integrated with optimized media and feed strategies and selected based on specifications, documentation, and protocol compatibility.
Functional cell culture additives support cell culture workflows across monoclonal antibodies (mAbs), recombinant proteins, microbial fermentation, viral vaccines, and gene therapy vectors. CHO workflows use antifoam, insulin, and titer enhancers to increase productivity. Microbial systems leverage antifoam for high-density fermentation. Viral production platforms use functional additives to enable suspension and adherent systems under cGMP conditions across development and commercial manufacturing.
CHO cell culture for monoclonal antibody production represents the primary application for functional additives. Fed-batch CHO processes can benefit from FoamAway antifoam during high-agitation culture phases and recombinant insulin to support metabolic requirements in chemically defined serum-free media. FunctionMAX TiterEnhancer can help increase volumetric productivity and titer achievement. A combination of optimized media, strategic feeding, and targeted functional additives aids in the development of high-yielding, scalable CHO manufacturing processes.
Microbial fermentation applications, including E. coli and yeast expression systems, can benefit from functional additives focused on foam control during high-density culture operations. FoamAway antifoam is designed to address foam formation during aeration and agitation of microbial cultures, particularly in fed-batch fermentation processes for plasmid DNA production, recombinant protein expression, and vaccine antigen manufacturing. Antifoam performance in microbial systems requires effective foam knockdown without interfering with oxygen transfer, cell growth, or downstream purification operations. These are considerations that inform both product selection and concentration optimization during process development.
Viral vaccine and gene therapy vector manufacturing using adherent and suspension cell culture platforms may incorporate functional additives to allow foam control and metabolic performance during virus production. Functional additives help address process challenges, including foam control in suspension bioreactor cultures, metabolic support during extended infection phases, and reagent quality requirements for viral vector and vaccine manufacturing under cGMP conditions. Applications include adeno-associated virus (AAV) vector production, lentiviral vector manufacturing, influenza vaccine production in MDCK or Vero cells, and other viral production platforms.
Functional additives work alongside Gibco cell culture media, feeds, supplements, and cell line development tools to optimize upstream workflows. Integrated product portfolios allow coordinated process development and consistent manufacturing operations.
For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.